BNP/CALL/ELI LILLY & CO/800/0.1/17.01.25 | Market Closed - Boerse Frankfurt Warrants 20:50:27 05/07/2024 BST | ||
| 15.64 EUR | +5.68% |
|
| Current month | +2.08% | ||
| 1 month | +51.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 05/07/24 | 15.73 | +6.28% |
| 04/07/24 | 14.8 | +1.16% |
| 03/07/24 | 14.63 | -4.75% |
| 02/07/24 | 15.36 | -1.16% |
| 01/07/24 | 15.54 | +0.84% |
Real-time Boerse Frankfurt Warrants
Last update July 05, 2024 at 08:50 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PZ1XP9 |
| ISIN | DE000PZ1XP94 |
| Date issued | 30/11/2023 |
| Strike | 800 $ |
| Maturity | 17/01/2025 (195 Days) |
| Parity | 10 : 1 |
| Emission price | 2.58 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.9 € |
|---|---|
| Lowest since issue | 1.98 € |
| Delta | 0.77x |
| Omega | 4.164 |
| Premium | 6.03x |
| Gearing | 5.39x |
| Moneyness | 1.143 |
| Difference Strike | -114.6 $ |
| Difference Strike % | -14.32% |
| Spread | 0.02 € |
| Spread % | 0.13% |
| Theoretical value | 15.64 |
| Implied Volatility | 34.76 % |
| Total Loss Probability | 30.75 % |
| Intrinsic value | 10.57 |
| Present value | 5.071 |
| Break even | 969.55 € |
| Theta | -0.16x |
| Vega | 0.18x |
| Rho | 0.27x |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.6
USD
Average target price
870.3
USD
Spread / Average Target
-4.84%
- Stock Market
- Warrants
- Warrant
